SIG
52
5
CCL
51
4
EFX
44
-6
EXPD
43
-2
NEM
36
2
VRSK
54
-9
MRO
54
3
COP
60
4
CSCO
56
2
PCG
75
5
GOOG
69
4
FE
41
2
DVA
72
4
MAC
64
6
DRI
53
8
ILMN
60
10
OXY
60
4
GOOGL
59
3
CA
4
-8
TXN
45
3
SIG
52
5
CCL
51
4
EFX
44
-6
EXPD
43
-2
NEM
36
2
VRSK
54
-9
MRO
54
3
COP
60
4
CSCO
56
2
PCG
75
5
GOOG
69
4
FE
41
2
DVA
72
4
MAC
64
6
DRI
53
8
ILMN
60
10
OXY
60
4
GOOGL
59
3
CA
4
-8
TXN
45
3
Financhill
Back

Blueprint Medicines Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
30

BPMC
Blueprint Medicines

Last Price:
88.69
Seasonality Move:
10.1%
Sell
32

BMRN
Biomarin Pharmaceutical

Last Price:
69.50
Seasonality Move:
7.09%
Sell
30
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $88.58. The Score for BPMC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $69.51. The Score for BMRN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $88.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $69.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.96 Sell
Relative Strength Index (14 RSI): 45.15 Sell
Chaikin Money Flow: -108029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.66 - 92.08) Sell
Bollinger Bands (100): (91.1 - 110.3) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.27 Sell
Relative Strength Index (14 RSI): 30.29 Sell
Chaikin Money Flow: 1220572 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.28 - 84.92) Sell
Bollinger Bands (100): (75.4 - 88.56) Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.81 Sell
20-day SMA: 88.79 Sell
50-day SMA: 92.93 Sell
200-day SMA: 94.84 Sell
8-day EMA: 89.6 Sell
20-day EMA: 90.04 Sell
50-day EMA: 93.45 Sell
200-day EMA: 91.2 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.69 Sell
20-day SMA: 73.65 Sell
50-day SMA: 82.42 Sell
200-day SMA: 85.51 Sell
8-day EMA: 69.95 Sell
20-day EMA: 73.68 Sell
50-day EMA: 79.12 Sell
200-day EMA: 84.31 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.28 per share, and a decrease next year of $0.18 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):